Jewish General Hospital highlights CanCURE's research on World AIDS Day

December 1, 2014

The Jewish General Hospital (JGH) in Montréal took advantage of World AIDS Day to underline the importance of raising awareness of the AIDS pandemic caused by the spread of the HIV infection. The JGH also highlighted the scientific efforts of their researcher and CanCURE Principal Investigator Dr. Andrew Mouland, who's lab is located at the Lady Davis Institute (LDI) based at the JGH. Notably, work accomplished by his team was recently published this year in the prestigious Nature Communications (Valiente-Echeverría F et al. Nat. Commun. 2014). CanCURE joins the JGH organization and others across the world in supporting this World AIDS Day 2014 !


Read the news item on the Lady Davis Institute website >>

Read the news item on the Jewish General Hospital website >>


Press release from UNAIDS reporting new set of targets to reach:

Fast-Track: ending the AIDS epidemic by 2030  >>



Please reload

CanCURE à la 9e édition de Persistance du VIH pendant la thérapie, Miami, Floride, 2019

December 16, 2019

CanCURE at the 9th Edition of HIV Persistence During Therapy, Miami, Florida, 2019

December 16, 2019

Nouvelle publication du Codirigeant du Thème 2 de CanCURE, Jérôme Estaquier

December 2, 2019

Please reload

©2019 CanCURE


  • https://twitter.com/cancurehiv
  • White Facebook Icon
  • White YouTube Icon
  • White LinkedIn Icon